These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 15055293)

  • 1. Toxicological considerations in the application and interpretation of susceptibility biomarkers in epidemiological studies.
    De Roos AJ; Smith MT; Chanock S; Rothman N
    IARC Sci Publ; 2004; (157):105-25. PubMed ID: 15055293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toxicological considerations in the application and interpretation of DNA adducts in epidemiological studies.
    Swenberg JA
    IARC Sci Publ; 2004; (157):237-46. PubMed ID: 15055299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of biomarkers to elucidate genetic susceptibility to cancer.
    Au WW; Salama SA
    Environ Mol Mutagen; 2005; 45(2-3):222-8. PubMed ID: 15690341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evolution of industrial toxicology toward vanishing doses and the human genome].
    Colombi A; Buratti M; Rubino FM; Giampiccolo R; Pulvirenti S; Brambilla G
    Med Lav; 2003; 94(1):69-82. PubMed ID: 12768958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dialkyl phosphates as biomarkers of organophosphates: the current divide between epidemiology and clinical toxicology.
    Sudakin DL; Stone DL
    Clin Toxicol (Phila); 2011 Nov; 49(9):771-81. PubMed ID: 22077242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toxicogenomic approaches for understanding molecular mechanisms of heavy metal mutagenicity and carcinogenicity.
    Koedrith P; Kim H; Weon JI; Seo YR
    Int J Hyg Environ Health; 2013 Aug; 216(5):587-98. PubMed ID: 23540489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomarkers of inherited susceptibility and cancer.
    Rebbeck TR
    IARC Sci Publ; 2004; (157):91-103. PubMed ID: 15055292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of epidemiologic studies of genetic effects and gene-environment interactions.
    García-Closas M; Jacobs K; Kraft P; Chatterjee N
    IARC Sci Publ; 2011; (163):281-301. PubMed ID: 22997868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomarkers of susceptibility to chemical carcinogens: the example of non-Hodgkin lymphomas.
    Kelly RS; Vineis P
    Br Med Bull; 2014 Sep; 111(1):89-100. PubMed ID: 25114269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Biological Markers in Epidemiology: Concepts, applications, Perspectives (Part II)].
    Hoffmann W; Latza U; Ahrens W; Greiser KH; Kroke A; Nieters A; Schulze MB; Steiner M; Terschüren C; Wjst M
    Gesundheitswesen; 2002 Mar; 64(3):145-52. PubMed ID: 11904855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Issues in the epidemiological analysis and interpretation of intermediate biomarkers.
    Rundle A; Schwartz S
    Cancer Epidemiol Biomarkers Prev; 2003 Jun; 12(6):491-6. PubMed ID: 12814992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health related guide values for drinking-water since 1993 as guidance to assess presence of new analytes in drinking-water.
    Dieter HH
    Int J Hyg Environ Health; 2014 Mar; 217(2-3):117-32. PubMed ID: 23820379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strategic issues in the design and interpretation of studies on metabolic polymorphisms and cancer.
    Vineis P; Malats N
    IARC Sci Publ; 1999; (148):51-61. PubMed ID: 10493248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Issues in the design and interpretation of chronic toxicity and carcinogenicity studies in rodents: approaches to dose selection.
    Rhomberg LR; Baetcke K; Blancato J; Bus J; Cohen S; Conolly R; Dixit R; Doe J; Ekelman K; Fenner-Crisp P; Harvey P; Hattis D; Jacobs A; Jacobson-Kram D; Lewandowski T; Liteplo R; Pelkonen O; Rice J; Somers D; Turturro A; West W; Olin S
    Crit Rev Toxicol; 2007; 37(9):729-837. PubMed ID: 17957539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Environmental and chemical carcinogenesis.
    Wogan GN; Hecht SS; Felton JS; Conney AH; Loeb LA
    Semin Cancer Biol; 2004 Dec; 14(6):473-86. PubMed ID: 15489140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment and statistical modeling of the relationship between remotely sensed aerosol optical depth and PM2.5 in the eastern United States.
    Paciorek CJ; Liu Y;
    Res Rep Health Eff Inst; 2012 May; (167):5-83; discussion 85-91. PubMed ID: 22838153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of interaction between asbestos exposure and glutathione S-transferase M1 and T1 genotypes in lung carcinogenesis.
    Stücker I; Boffetta P; Antilla S; Benhamou S; Hirvonen A; London S; Taioli E
    Cancer Epidemiol Biomarkers Prev; 2001 Dec; 10(12):1253-8. PubMed ID: 11751442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exposure biomarkers for the study of toxicological impact on carcinogenic processes.
    Farmer PB
    IARC Sci Publ; 2004; (157):71-90. PubMed ID: 15055291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Markers of genetic susceptibility in human environmental hygiene and toxicology: the role of selected CYP, NAT and GST genes.
    Thier R; Brüning T; Roos PH; Rihs HP; Golka K; Ko Y; Bolt HM
    Int J Hyg Environ Health; 2003 Jun; 206(3):149-71. PubMed ID: 12872524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.